Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing
Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion
Who this might be right for
Atopic Dermatitis
Novartis 20